...
首页> 外文期刊>Rapid Communications in Mass Spectrometry: RCM >High-throughput analysis in drug discovery: application of liquid chromatography/ion-trap mass spectrometry for simultaneous cassette analysis of alpha-1a antagonists and their metabolites in mouse plasma
【24h】

High-throughput analysis in drug discovery: application of liquid chromatography/ion-trap mass spectrometry for simultaneous cassette analysis of alpha-1a antagonists and their metabolites in mouse plasma

机译:高通量分析在药物开发中的应用:液相色谱/离子阱质谱技术在同时测定小鼠血浆中的α-1a拮抗剂及其代谢产物的应用

获取原文
获取原文并翻译 | 示例

摘要

The application of liquid chromatography/ion-trap mass spectrometry for simultaneous quantification of multiple drugs and detection of their metabolites for in vitro experiments was reported recently. In the current study, the use of these techniques was extended to in vivo pharmacokinetic (PK) studies of ar-la antagonists. In combination with limited time-point PK, greatly increased throughput was demonstrated for the in vivo screening and investigation of in vivo-in vitro correlation. In addition to quantitative analyses, the technique allowed simultaneous detection of major in vivo metabolites without having to reanalyze the plasma samples. The drugs were individually dosed in mice intravenously via tail vein injection and the blood samples were collected 5 min and 2 h after dosing. After the plasma samples for the different drugs had been prepared separately, they were pooled for cassette analysis. The concentrations of five test compounds in the plasma samples at 2 h ranged from 36-1062 ng/mL, whereas their 5-min plasma levels were similar. From the same cassette analysis, major metabolites in the samples were also detected simultaneously through the interpretation of full-scan mass spectra. The metabolite identification confirmed the results from a previous report that the major sites of metabolism are hydroxylation of the phenyl ring not bearing the alkylsulfonamide substitutent, piperidine N-dealkylation, and N-demethylation of the alkylsulfonamide group. Copyright (C) 2001 John Wiley & Sons, Ltd. [References: 16]
机译:最近报道了液相色谱/离子阱质谱技术在同时定量多种药物和检测其代谢物用于体外实验中的应用。在当前的研究中,这些技术的使用已扩展到ar-1a拮抗剂的体内药代动力学(PK)研究。与有限的时间点PK结合使用,可大大提高通量,用于体内筛选和体内-体外相关性研究。除了定量分析外,该技术还允许同时检测主要的体内代谢产物,而无需重新分析血浆样品。通过尾静脉注射将药物分别静脉内给药于小鼠,并在给药后5分钟和2小时收集血样。分别准备好不同药物的血浆样品后,将它们合并进行盒分析。 2 h血浆样品中五种测试化合物的浓度范围为36-1062 ng / mL,而它们的5分钟血浆水平相似。从同一盒分析中,还通过全扫描质谱的解释同时检测到了样品中的主要代谢产物。代谢物的鉴定证实了先前报道的结果,即主要的代谢位点是不带有烷基磺酰胺取代基的苯环的羟基化,哌啶的N-脱烷基和烷基磺酰胺基团的N-脱甲基。版权所有(C)2001 John Wiley&Sons,Ltd. [引用:16]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号